Innoviva Inc (NASDAQ:INVA)

14.24
Delayed Data
As of Jan 24
 -0.13 / -0.90%
Today’s Change
10.03
Today|||52-Week Range
20.54
+0.56%
Year-to-Date
Will Theravance Biopharma Finally Break Out in 2020?
Jan 14 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close14.37
Today’s open14.37
Day’s range14.16 - 14.41
Volume328,568
Average volume (3 months)637,825
Market cap$1.4B
Data as of 4:00pm ET, 01/24/2020

Growth & Valuation

Earnings growth (last year)+213.38%
Earnings growth (this year)-51.70%
Earnings growth (next 5 years)+1.60%
Revenue growth (last year)+18.95%
P/E ratio4.3
Price/Sales7.20
Price/Book9.39

Competitors

 Today’s
change
Today’s
% change
CNSTConstellation Pharma...+0.19+0.52%
AMRXAmneal Pharmaceutica...-0.36-7.07%
TBPHTheravance Biopharma...+0.33+1.28%
YMABY-mAbs Therapeutics,...+0.20+0.57%
Data as of 6:30pm ET, 01/24/2020

Financials

Next reporting dateFebruary 4, 2020
EPS forecast (this quarter)$0.50
Annual revenue (last year)$274.8M
Annual profit (last year)$395.1M
Net profit margin143.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Brisbane, California

Forecasts